新的1,2,3-triazole-linked (±) -agrimonolide衍生物作为抗性结肠炎药物,可以抑制JAK1/STAT3通路
Xiao Zhang1,2, Ming-Qian Ju1,2, Heng-Li Yang1,2
1Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming, 650500, China.
Molecular diversity
|September 23, 2025
概括
新的1,2,3-triazole衍生物显示出对性结肠炎 (UC) 有强大的抗炎作用. 化合物6d通过抑制炎症媒介和JAK1/STAT3通路来缓解UC,提供了一个有前途的治疗途径.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病,治疗选择有限.
- 现有的UC治疗方法具有显著的副作用和可变的疗效.
- 迫切需要针对炎症途径的新型治疗策略.
研究的目的:
- 设计,合成和评估新型1,2,3-triazole-linked (±) -Agrimonolide衍生物的抗炎活性.
- 研究这些衍生物在治疗性结肠炎中的潜力.
- 阐明最强效化合物的作用机制.
主要方法:
- 一系列与1,2,3-triazole相关的 (±) -Agrimonolide衍生物的合成.
- 在体外评估氧化物 (NO) 生产抑制.
- 在肠道炎症模型中对抗炎作用的体内评估.
- 对JAK1/STAT3通路抑制的分析.
主要成果:
- 大多数合成的三醇衍生物在体外有效抑制了NO的产生.
- 与 (±) -阿格里莫诺利德和甲相比,一些化合物表现出更高的抗炎活性.
- 化合物6d显著抑制了结肠组织中的炎症媒介,并缓解了UC症状.
- 化合物6d的有效性与抑制JAK1/STAT3信号通路有关.
结论:
- 1,2,3-triazole-linked (±) -Agrimonolide衍生物具有显著的抗炎性质. 这种抗炎性质是由于其具有抗炎性质.
- 化合物6d是性结肠炎治疗的有希望的候选物,因为它能够通过JAK1/STAT3通路调节炎症反应.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
463
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
463
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
944
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
944
Inflammatory Bowel Disease IV: Pharmacological Management
528
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
528
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.1K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
493
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
493
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
574
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
574

